| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/21/2010 | CN101781637A Human 5,10-methenyltetrahydrofolate, and crystallization methods, crystals and application of composites thereof |
| 07/21/2010 | CN101781635A Plant cell having animal-type sugar chain adding function |
| 07/21/2010 | CN101781368A Anti-amyloid beta antibodies and their use |
| 07/21/2010 | CN101781365A Artificial antigen of tetraodotoxin and corresponding specific antibody and preparation method and application thereof |
| 07/21/2010 | CN101121748B Infectivity resistant bursal disease virus VP4 protein monoclonal antibody |
| 07/20/2010 | US7759477 Immunoglobulin for use in detection of simian and lymphadenopathy associated viral infection in mammals; immunodiagnostics |
| 07/20/2010 | US7759476 Double-stranded RNAS directed to IKK-2 |
| 07/20/2010 | US7759466 Monoclonal antibodies to alpha-amylase |
| 07/20/2010 | US7759465 selectively inhibit induction of cytokines by human peripheral blood mononuclear cells (PBMCs) stimulated with ara-lipoarabinomannan (araLAM); for inflammation |
| 07/20/2010 | US7759464 N-glycosylated antibody |
| 07/20/2010 | US7759463 RNA interference pathway genes as tools for targeted genetic interference |
| 07/20/2010 | US7759462 detecting Tir polypeptide of escherichia by contacting a sample with an anti-Tir (translocated intimin receptor) antibody immunospecific to the Tir polypeptide and detecting immunospecific binding of the anti-Tir antibody to the Tir polypeptide;kits |
| 07/20/2010 | US7759314 Stabilizing collagen VI-deficient dystrophin-associated protein complexes (DAPCs) on the surface of a cell by contacting the cell with an effective amount of a biglycan therapeutic; treatment of muscular dystrophies |
| 07/20/2010 | US7759091 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 07/20/2010 | US7759070 Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates |
| 07/20/2010 | US7758870 Virulent isolate of Lawsonia intracellularis; protecting against and diagnosing porcine proliferative enteropathy |
| 07/20/2010 | US7758863 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 07/20/2010 | US7758859 monoclonal antibody or an Fab fragment capable of binding to mouse Vascular endothelial cell growth factor (VEGF) and human VEGF; cancer, diabetes related diseases, age-induced macular degeneration |
| 07/20/2010 | US7758858 Nucleotide sequences coding tumor necrosis factor binding proteins for prevention and treatment of bone disorders |
| 07/20/2010 | US7758855 DNA promoters and anthrax vaccines |
| 07/20/2010 | CA2446942C Use of il-18 inhibitors for the treatment or prevention of sepsis |
| 07/20/2010 | CA2421339C Novel polypeptides and nucleic acids encoding the same |
| 07/20/2010 | CA2410586C Recombinant or purified polyclonal antibodies for treating allergy |
| 07/20/2010 | CA2389250C Antibody catalysis of enantio- and diastereo-selective aldol reactions |
| 07/20/2010 | CA2309679C Method of identifying binding site domains that retain the capacity of binding to an epitope |
| 07/20/2010 | CA2305864C Transgenic reduction of sinapine in crucifera |
| 07/20/2010 | CA2289980C Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays |
| 07/20/2010 | CA2271249C Macromolecular neuraminidase-binding compounds |
| 07/20/2010 | CA2191063C Dna encoding glutamate gated chloride channels |
| 07/20/2010 | CA2105449C An interferon-.alpha./.beta. binding protein, its preparation and pharmaceutical compositions containing it |
| 07/15/2010 | WO2010081173A2 Modified antibody compositions, methods of making and using thereof |
| 07/15/2010 | WO2010080935A1 Monoclonal antibodies against pcbp-1 antigens, and uses therefor |
| 07/15/2010 | WO2010080836A2 Antibacterial and antifungal peptides |
| 07/15/2010 | WO2010080623A2 Anti-fxi antibodies and methods of use |
| 07/15/2010 | WO2010080528A1 Hepatitis c virus combination therapy |
| 07/15/2010 | WO2010080065A1 Affinity chromatography matrix |
| 07/15/2010 | WO2010080062A1 Separation method using single polymer phase systems |
| 07/15/2010 | WO2010079850A2 Agent for prophylaxis or treatment of cancer |
| 07/15/2010 | WO2010079510A2 Anti-rhd monoclonal antibodies |
| 07/15/2010 | WO2010079189A1 Display vectors and methods and uses thereof |
| 07/15/2010 | WO2010079161A1 A b cell depleting agent for the treatment of atherosclerosis |
| 07/15/2010 | WO2010079149A1 Fusion antibody |
| 07/15/2010 | WO2010078950A2 Antigens associated with endometriosis, psoriatic arthritis and psoriasis |
| 07/15/2010 | WO2010057503A3 Curcumin protein conjugates |
| 07/15/2010 | WO2010048026A3 Fibroblast growth factor receptor-3 (fgfr-3) inhibitors and methods of treatment |
| 07/15/2010 | WO2010044506A3 Tmprss4-specific human antibody |
| 07/15/2010 | WO2010040736A3 Amino acid sequences directed against il18 and/or the il-18 receptor and polypeptides comprising the same for the treatment of diseases and/or disorders associated with il-18 mediated signaling |
| 07/15/2010 | WO2010039873A3 Humanized endoglin antibodies |
| 07/15/2010 | WO2010037835A3 Cross-species-specific pscaxcd3, cd19xcd3, c-metxcd3, endosialinxcd3, epcamxc d3, igf-1rxcd3 or fapalpha xcd3 bispecific single chain antibody |
| 07/15/2010 | WO2010032899A3 Eno1-specific human antibody |
| 07/15/2010 | WO2010029513A3 Pcsk9 antagonists |
| 07/15/2010 | WO2010025400A3 Cross-reactive and bispecific anti-el 17a/f antibodies |
| 07/15/2010 | WO2009155726A3 Humanization of rabbit antibodies using a universal antibody framework |
| 07/15/2010 | WO2009147248A3 Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases |
| 07/15/2010 | US20100179307 Biomaker composition for detecting diabetic retinopathy and diagnostic kit therefor |
| 07/15/2010 | US20100179306 Antibodies for identifying and/or isolating at least one cell population |
| 07/15/2010 | US20100179303 Site-specific conjugation of ligands to nanoparticles |
| 07/15/2010 | US20100178296 Antibodies to cd200r |
| 07/15/2010 | US20100178295 Compositions and methods for the therapy and diagnosis of influenza |
| 07/15/2010 | US20100178293 Use of antibodies against the cd52 antigen for the treatment of neurological disorders, particularly transmissible spongiform encephalopathy and alzheimer's disease |
| 07/15/2010 | US20100178292 Cryptic glycan markers and applications thereof |
| 07/15/2010 | US20100178290 Methods for reducing viral load in HIV-1 infected patients |
| 07/15/2010 | US20100178242 Labelling methods |
| 07/15/2010 | DE102009017716A1 New polypeptide comprising a variable domain of heavy chain of human or camelids antibody, a constant domain of light chain and optionally a linker, useful for diagnosis, treatment and/or prevention of infections associated with e.g. HIV |
| 07/15/2010 | CA2749339A1 Modified antibody compositions, methods of making and using thereof |
| 07/15/2010 | CA2749093A1 Methods and compositions for improving efficiency of nucleic acids amplification reactions |
| 07/15/2010 | CA2748807A1 Separation method using single polymer phase systems |
| 07/15/2010 | CA2748401A1 Antigens associated with endometriosis, psoriatic arthritis and psoriasis |
| 07/15/2010 | CA2747519A1 Anti-fxi antibodies and methods of use |
| 07/15/2010 | CA2747248A1 Hepatitis c virus combination therapy |
| 07/15/2010 | CA2746350A1 Anti-rhd monoclonal antibodies |
| 07/15/2010 | CA2744670A1 A b cell depleting agent for the treatment of atherosclerosis |
| 07/14/2010 | EP2207038A1 Method for prediction of postoperative prognosis, and diagnosis kit |
| 07/14/2010 | EP2207034A1 Antibodies for use in the treatment of HIV infections |
| 07/14/2010 | EP2206784A1 Unsaturated fatty acid synthase gene originating in marchantiales plant and utilization of the same |
| 07/14/2010 | EP2206783A1 Unsaturated fatty acid synthase gene originating in marchantiales plant and utilization of the same |
| 07/14/2010 | EP2206775A1 Anti-il-6 receptor antibody |
| 07/14/2010 | EP2206729A1 Antibodies for identifiying and/or isolating at least one cell population which is selected from the group comprising haematopoietic stem cells, neuronal stem cells, neuronal precursor cells, mesenchymal stem cells and mesenchymal precursor cells |
| 07/14/2010 | EP2206728A1 Methods for treating bone cancer pain by administering a nerve growth factor antagonistic antibody |
| 07/14/2010 | EP2206727A1 ANTIBODY TARGETING OSTEOCLAST-RELATED PROTEIN Siglec-15 |
| 07/14/2010 | EP2206720A1 Albumin fusion proteins |
| 07/14/2010 | EP2206517A1 Immunopotentiating compositions comprising anti-PD-L1 antibodies |
| 07/14/2010 | EP2206516A1 Stabilized liquid anti-RSV antibody formulations |
| 07/14/2010 | EP2205977A1 Use of tenascin-w as a biomarker for colon cancer |
| 07/14/2010 | EP2205735A2 Immunological tests for the presence of bacteria which make use of antibodies obtained using a specific method |
| 07/14/2010 | EP2205725A2 Cell rolling separation |
| 07/14/2010 | EP2205640A2 Antibodies that bind il-4 and/or il-13 and their uses |
| 07/14/2010 | EP2205639A2 Anti-pcsk9 and methods for treating lipid and cholesterol disorders |
| 07/14/2010 | EP2205637A1 Il-23 antibodies |
| 07/14/2010 | EP2205636A2 Human gm-csf antigen binding proteins |
| 07/14/2010 | EP2205635A1 Antigen binding proteins capable of binding thymic stromal lymphopoietin |
| 07/14/2010 | EP2205634A2 Anti-neublastin antibodies and uses thereof |
| 07/14/2010 | EP2205633A1 New antibodies specific of the -amyloid peptides and their uses as diagnostic agents or drugs |
| 07/14/2010 | EP2205632A2 Use of anti-amyloid beta antibody in ocular diseases |
| 07/14/2010 | EP2205631A2 Humanized antibody |
| 07/14/2010 | EP2205630A1 Antibody against anthrax toxins |
| 07/14/2010 | EP2205627A1 Anticomplement polypeptides of ixodes ricinus |
| 07/14/2010 | EP2205622A1 High-pressure refolding of monoclonal antibody aggregates |
| 07/14/2010 | EP2205277A1 Novel antibody therapies |
| 07/14/2010 | EP2205276A2 Anti-il-12/23p40 antibodies, epitopes, formulations, compositions, methods and uses |